TLR4 and Thrombocytopenia: LPS administration did not inhibit the ability of IVIg or KM114 to ameliorate antibody induced thrombocytopenia, suggesting that putative ligation of TLR4 with LPS does not affect the therapeutic properties of IVIg or KM114.